Liver Glandular Extract Capsules
Capsules of desiccated liver glandular tissue for detoxification organotherapy support. Classifies under HTS 3001.90.01.95 as organotherapeutic animal substance.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Hepatitis-free source certification
• Heavy metal detox validation testing
• Distinguish from nutritional liver powder
Related Products under HTS 3001.90.01.95
Dried Bovine Thymus Gland Powder
Powdered extract from bovine thymus glands used in organotherapy to support immune function and treat conditions like chronic fatigue. It falls under HTS 3001.90.01.95 as a dried organ preparation for therapeutic uses, derived from animal glands for organotherapeutic purposes.
Porcine Pancreatic Enzyme Extract
Extract from pig pancreas glands providing digestive enzymes for therapeutic treatment of pancreatic insufficiency. Classified under HTS 3001.90.01.95 as an organ extract prepared for organotherapeutic uses.
Heparin Sodium USP Powder
Purified salt of heparin extracted from porcine intestinal mucosa, used as an anticoagulant for therapeutic and prophylactic blood clotting prevention. Falls under HTS 3001.90.01.95 as a prepared animal substance for therapeutic uses.
Desiccated Thyroid Gland Tablets
Dried and powdered porcine thyroid glands standardized for hormone content, used therapeutically for hypothyroidism treatment. HTS 3001.90.01.95 covers this organotherapeutic glandular preparation.
Adrenal Cortex Extract Powder
Powdered extract from bovine adrenal cortex glands for organotherapy in adrenal insufficiency and stress-related conditions. Classifies under HTS 3001.90.01.95 as a therapeutic organ extract.
Ovarian Glandular Extract Capsules
Capsules containing dried extracts from porcine or bovine ovaries for hormone replacement organotherapy in women. HTS 3001.90.01.95 applies to these prepared glandular substances for therapeutic use.